Recombinant Protein Expression: Boster Biological Technology Leads in Custom Antibody Production Services

Boster Biological Technology is revolutionizing molecular biology with its advanced recombinant protein expression and custom antibody services, offering high-quality solutions for global research and diagnostics.

Pleasanton, California, United States – December 18, 2024 —

Founded in 1993, Boster Biological Technology has become a trusted name in molecular biology, focusing on antibody and protein research. Today, it is making waves with its advanced offerings in recombinant protein expression services and custom antibody production, setting benchmarks in life sciences by delivering precision-focused solutions for research laboratories worldwide.

With over three decades of industry experience and unparalleled expertise in ELISA kits and antibody development, Boster Biological Technology has developed a catalog of over 20,000 antibodies and ELISA kits. 

The company is a leader in the field of molecular biology and immunology and continues to enable groundbreaking discoveries in life sciences. Boasting over 20 years of protein production, Boster Biological Technology has a proven track record with a 98% expression success rate and over 3000 expressions annually.

Recombinant protein expression is one of Boster Biological Technology’s core competencies. This service caters to researchers requiring high-quality recombinant proteins for cellular biology, immunology, and drug discovery studies. The company employs a range of expression systems, including bacterial, mammalian, and insect cells, ensuring that clients receive proteins tailored to meet their functional and structural requirements.

The company’s custom antibody services have gained recognition for delivering antibodies that meet stringent specifications. Whether antigen design or final antibody production, its custom antibody services boast a pipeline that includes peptide synthesis, antigen conjugation, immunization, and hybridoma screening, culminating in specific monoclonal or polyclonal antibodies. Boster Biological Technology’s clients benefit from end-to-end support, including epitope mapping and validation, making its services ideal for diagnostic and therapeutic applications.

With over three decades of experience in the field, Boster Biological Technology is renowned as an ELISA expert. Its extensive catalog of ELISA kits supports applications across immunology, neuroscience, and oncology. The company’s kits are meticulously validated to ensure high sensitivity and accuracy, contributing to its reputation as a trusted partner for academic and pharmaceutical researchers.

“Our foundations always go back to maintaining quality and having strong integrity to deliver consistent products and services. Providing reliable and high-quality products is our passion. This is our way of helping the life science community thrive, helping more researchers get the best tools to move forward,” said Steven Xia, the founder of Boster Biological Technology.

For more information, visit https://www.bosterbio.com/

Committed to quality, innovation, and customer satisfaction, Boster Biological Technology stands out by integrating advanced purification methods, resulting in proteins with high activity and purity levels. By maintaining strict quality control at every stage, the company ensures consistency and reproducibility, key factors for researchers conducting sensitive experiments.

The company’s recombinant protein expression services are noteworthy for their scalability, accommodating small-scale research projects to large-scale industrial demands. Additionally, the company’s proprietary antibody validation techniques ensure that each product exceeds industry standards for specificity and sensitivity.

Boster Biological Technology also offers ELISA troubleshooting support, setting it apart as a company that puts its customers’ success first. Researchers facing technical challenges with ELISA experiments can rely on Boster’s expertise to achieve optimal results.

Taking a bold approach to research with investments in scientific collaboration, Boster Biological Technology regularly partners with research institutions and biotechnology firms to drive innovations in antibody and protein science. This collaborative ethos strengthens its position as a go-to provider of cutting-edge research tools.

With over 30 years of designing high-affinity antibodies and immunoassays, Boster Biological Technology serves clients across the globe, offering expedited shipping and technical support. Founded on a bedrock of quality and integrity, its ability to address diverse research needs in an ever-evolving scientific landscape underscores its leadership in molecular biology solutions.

About the Company:

Founded in 1993, Boster Biological Technology is a leading provider of high-quality custom antibody production and recombinant protein expression services. Known for its expertise in ELISA, the company delivers precision-driven solutions for molecular biology, immunology, and drug discovery. Boster offers tailored services, including protein purification, custom monoclonal and polyclonal antibody development, and ELISA kits, ensuring researchers achieve reliable and reproducible results. With a strong commitment to innovation and customer success, Boster serves global clients, partnering with academic, pharmaceutical, and biotech sectors to advance scientific discovery and development.

Contact Info:
Name: CJ Xia
Email: Send Email
Organization: Boster Biological Technology
Address: 3942 Valley Ave Pleasanton, CA 94566, USA
Phone: (888) 466-3604
Website: https://www.bosterbio.com/

Release ID: 89149034

Should any problems, inaccuracies, or doubts arise from the content contained within this press release, we kindly request that you inform us immediately by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your concerns within 8 hours, taking necessary steps to rectify identified issues or assist with the removal process. Providing accurate and dependable information is at the core of our commitment to our readers.